title: Group A Streptococcus invasive infections: a review.
abstract: The incidence of group A Streptococcus (GAS) invasive infections has been increasing worldwide, and there is no obvious explanation for this phenomenon. In 1993, a working group on severe GAS infections was established to define accurately what constitutes an invasive infection. Three types of infection are particularly feared: necrotizing fasciitis, myositis and a newly defined entity, named streptococcal toxic shock syndrome (STSS) because of a certain analogy with its staphylococcal counterpart. GAS produces many toxins responsible for its clinical manifestations. Some of them, labelled streptococcal pyrogenic exotoxins, have been characterized as superantigens. These proteins play a key role in initiating the immune response to GAS and are mostly responsible for the precipitous course of invasive infections. Death rates are high in streptococcal invasive infections, ranging from about 20% for necrotizing fasciitis to almost 100% for myositis. Therapy consists mainly of high doses of antibiotic combinations, aggressive surgery, and intravenous administration of immunoglobulins for STSS.
authors.affiliation: Department of Microbiology and Infectious Diseases, Hôpital Maisonneuve-Rosemont, Université de Montréal, Que.
authors.forename: K A
authors.initials: KA
authors.lastname: Weiss
authors.forename: M
authors.initials: M
authors.lastname: Laverdière
mesh_terms: D000328:Adult; D000818:Animals; D004195:Disease Models, Animal; D019115:Fasciitis, Necrotizing / Q000175:diagnosis; D006801:Humans; D008875:Middle Aged; D009220:Myositis / Q000175:diagnosis; D012772:Shock, Septic / Q000175:diagnosis; D013290:Streptococcal Infections / Q000145:classification / Q000628:therapy*; D013297:Streptococcus pyogenes / Q000302:isolation & purification* / Q000472:pathogenicity